Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
The Journal of Reproductive Medicine|June 8, 2001
Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimenB de LignieresAnnals of Medicine|June 1, 1993
Transdermal dihydrotestosterone treatment of 'andropause'B de LignieresCurrent Opinion in Obstetrics & Gynecology|June 1, 1993
The case for a nonplasma lipoprotein etiology of reduced vascular risk in estrogen replacement therapyB de LignieresMaturitas|April 1, 1995
Influence of route of administration on progesterone metabolismB de Lignieres, L Dennerstein, T BackstromAmerican Journal of Obstetrics and Gynecology|September 1, 1983
Differential lipemic and hormonal responses to oral and parenteral 17 beta-estradiol in postmenopausal womenA Basdevant, B De Lignieres, B Guy-GrandJournal of Psychosomatic Obstetrics and Gynaecology|March 1, 1996
Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administrationW Vanselow, L Dennerstein, K M Greenwood, et al.Diabete & Metabolisme|March 1, 1981
Estradiol, progesterone and plasma lipids during the menstrual cycleA Basdevant, B De Lignieres, B Bigorie, et al.Fertility and Sterility|May 1, 1993
Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changesD L Moyer, B de Lignieres, P Driguez, et al.Maturitas|October 1, 1980
Absorption of percutaneous oestradiol in postmenopausal womenR Sitruk-Ware, B de Lignieres, A Basdevant, et al.Pageof 2